Theralase Technologies Research Successfully Destroys Breast Cancer Cells
 

Theralase Technologies Inc. (TSX VENTURE:TLT) announces revolutionary results of a pre-clinical study of its patented photodynamic compounds (PDCs) and their ability, when used with Theralase lasers, to destroy breast cancer cells. Theralase plans to submit results to the US Food and Drug Administration and Health Canada, as part of its collaborative work with Virginia Tech...

More...